Guias de Practica Clínica

Ascitis, peritonitis bacteriana espontánea, Síndrome Hepatorenal:

1. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010 Sep;53(3):397-417

 

2.- Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Francesco Salerno, Alexander Gerbes, Pere Ginès, Florence Wong, and Vicente Arroyo. Gut 2007; 56(9): 1310-18.

 

3.-Management of adult patients with ascites due to cirrhosis: an Update. Bruce A. Runyon. Hepatology 2009; 49(6): 2087-2107.

link: HTML

 

Hemorragia por Hipertensión portal

1.- Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis. Guadalupe Garcia-Tsao, Arun J. Sanyal, Norman D. Grace, William Carey, and the Practice Guidelines Committee of the American Association for the Study of Liver Diseases, the Practice Parameters Committee of the American College of Gastroenterology. Hepatology 2007; 46(3): 922-938.

link: HTML

 

2.- Revising Consensus in portal hypertension: Report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. Roberto de Franchis on behalf of the Baveno Faculty. J Hepatol 2010; 53(4): 762-68.

link: PDF (415 KB)

 

3. Hipertensión Portal: recomendaciones para su evaluación y tratamiento. Documento de consenso auspiciado por la AEEH y el CIBERehd. Jaume Bosch, Juan G. Abraldes, Agustín Albillos, Carles Aracil, Rafael Bañares, Annalisa Berzigotti, Jose Luís Calleja, Joaquin de la Peña, Angels Escorsell, Juan Carlos García-Pagán, Joan Genesca, Manuel Hernandez-Guerra, Cristina Ripoll, Ramón Planas y Candid Villanueva. Gastroenterología y Hepatología 2012; 35(6): 421-50.

link: HTML

Hepatopatía alcohólica:

1. Alcoholic liver disease. Robert S. O’Shea, Srinivasan Dasarathy, Arthur J. McCullough, and the Practice Guideline Committee of the American Association for the Study of Liver Diseases and the Practice Parameters Committee of the American College of Gastroenterology. Hepatology 2010; 51(1): 307-328.

link: HTML

 

2. EASL Clinical Practical Guidelines: Management of alcoholic liver disease. J. Hepatol 2012;zz:xxx

Link: HTML

 

Hemocromatosis:

1. EASL clinical practice guidelines for HFE hemochromatosis. J Hepatol 2010; 53(1): 3-22

 

2. Diagnosis and management of hemochromatosis: 2011 Practice Guideline by the American Association for the Study of Liver Diseases. Bruce R Bacon, Paul C Adams, Kris V Kowdley, Lawrie W Powell, and Anthony S Tavill. Hepatology 2011; 54(1): 328-343

link: HTML

 

Enfermedad de Wilson

1. Diagnosis and treatment of Wilson disease: An update. Eve A Roberts and Michael L Schilsky. Hepatology 2008; 47(6): 2089-2111.

link: HTML

 

2. EASL Clinical Practice Guidelines: Wilson’s disease. Journal of Hepatology 2012(56): 671-685

Link: HTML

 

Hepatitis autoinmune

1. Diagnosis and Management of Autoinmune Hepatitis. Michael P Manns, Albert J Czaja, James D Gorham, Edward L Krawitt, Giorgina Mieli-Vergani, Diego Vergani, and John M Vierling. Hepatology 2010; 51(6): 2193-2213.

link: HTML

 

Hepatopatías colestáticas

1. EASL Clinical Practice Guidelines: Management of cholestatic liver diseases. J Hepatol 2009; 51(2): 237-267.

 

2. Primary Biliar Cirrhosis. Keith D Lindor, M Eric Gershwin, Raoul Poupon, Marshall Kaplan, Nora V Bergasa, E Jenny Heathcote, and American Association for Study of Liver Diseases. Hepatology 2009; 50(1): 291-308.

link: HTML

 

3. Diagnosis and management of Primary Sclerosing Cholangitis. Roger Chapman, Johan Fevery, Anthony Kalloo, David M Nagorney, Kirsten Muri Boberg, Benjamin Shneider, and Gregory J Gores. Hepatology 2010; 51(2): 660-678.

link: HTML

 

4. Update on primary sclerosing cholangitis. Tom H. Karlsen, Kierten Muri Boberg. J Hepatol 2013; 59:571-82

Link: HTML

 

Hepatitis B:

1. EASL Clinical Practice Guidelines: Management of chronic hepatitis B. J Hepatol 2009; 50: 227-242

 

2. Chronic hepatitis B: Update 2009. A Lok and B. McMahon. Hepatology 2009; 50(3): 661-662

link: HTML

 

3. Chronic hepatitis B. A Lok and B. McMahon. Hepatology 2007; 45: 507-539.

link: HTML

 

4. EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection. Journal of Hepatology 2012 (in press).

link: HTML

 

5. Documento de Consenso de la AEEH sobre el tratamiento de la infección por el virus de la Hepatitis B (2012). María Buti, Javier García-Samaniego, Martín Prieto, Manuel Rodriguez, José María Sánchez-Tapias, Emilio Suarez y Rafael Esteban. Gastroenterología y Hepatología 2012; 35(7):512-28

Link: HTML

Hepatitis C:

1. EASL Clinical Practice Guidelines: Management of hepatitis C virus infection. J Hepatol. 2011 Aug;55(2):245-64

 

2. Diagnosis, management and treatment of hepatitis C: an update. Ghany MG, Strader DB, Thomas DL, Seeff LB; American Association for the Study of Liver Diseases. Hepatology. 2009 Apr;49(4):1335-74.

link: HTML

 

3. An Update on treatment of Genotype 1 Crhonic Hepatitis C Virus Infection: 2011 Practice Guideline by the American Association for the Study of Liver Diseases. Ghany MG, Nelson DR, Strader DB, Thomas DL, Seeff LB. Hepatology 2011;54(4): 1433-44

link:HTML

 

4. Dermatological side effects of hepatitis C and its treatment: Patient management in the era of direct-acting antivirals. Cagoub P, Bourliere M, Lübbe J, Dupin N, Buggisch P, Dusheiko G, Hézode C, Picard O, Pujol R, Segaert S, Thio B, Roujeau JC; J Hepatol 2012; 56: 455-63.

link:HTML

 

5. Criterios y recomendaciones generales para el tratamiento con Boceprevir y Telaprevir de la Hepatitis Crónica C en pacientes monoinfectados. Informe de utilidad terapéutica del 28.02.2012, Ministerio de Sanidad, Servicios Sociales e Igualdad & Agencia Española del Medicamento y Productos Sanitarios.

link: HTML

 

6. Criterios y recomendaciones generales para el tratamiento con Boceprevir y Telaprevir de la Hepatitis Crónica C en pacientes infectados por el VIH, en trasplantados hepáticos y en población pediátrica. Recomendaciones de uso de medicamentos en condiciones distintas a las autorizadas (20.03.2012), Ministerio de Sanidad, Servicios Sociales e Igualdad & Agencia Española del Medicamento y Productos Sanitarios.

link: HTML

 

7. UK consensus guidelines for the use of the protease inhibitors boceprevir and telaprevir in genotype 1 chronic hepatitis C infected patients. P. Ramachandran, A. Fraser, K. Agarwal, A. Austin, A. Brown, G.R. Foster, R. Fox, P.C. Hayes, C. Leen, P.R. Mills, D.J.Mutimer, S.D. Ryder, J.F. Dillon. Aliment Pharmacol Ther 2012; 35: 647-62

Link: HTML

 

8. EASL Clinical Practice Guidelines: Management of hepatitis C virus infection. J Hepatol (2013), http://dx.doi.org/10.1016/j.jhep.2013.11.003 

Link: HTML

 

9. Management of anemia induced by triple therapy in patients with chronic hepatitis C: challenges, opportunities and recommendations. Manuel Romero-Gómez, Marina Berenguer, Esther Molina, José Luís Calleja

Link: HTML

 

Enfermedades vasculares hepáticas:

1. Vascular disorders of the liver. Laurie D. DeLeve,1 Dominique-Charles Valla,2 and Guadalupe Garcia-Tsao. Hepatology 2009; 49(5): 1729-1764.

link: HTML

 

Hepatocarcinoma

1. Diagnosis and treatment of hepatocellular carcinoma. Alejandro Forner, Carmen Ayuso, María Isabel Real, Javier Sastre, Ricardo Robles, Bruno Sangro, María Varela, Manuel de la Mata, María Buti, Luís Martí-Bonmatí, Concepció Bru, Josep Tabernero, Josep M Llovet, and Jordi Bruix. Med Clin (barc) 2009; 132(7): 272-287.

link: Español

 

2. Management of Hepatocellular Carcinoma: An Update. Jordi Bruix and Morris Sherman. Hepatology 2010; 52(1): 1020-22

link:

 

3. Management of Hepatocellular Carcinoma: An Update. Jordi Bruix and Morris Sherman. Hepatology 2011; 53(3): 1020-1022.

link: HTML

 

4. EASL – EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma. Journal of Hepatology 2012 (56): 908-43

Link: HTML

 

5. Tumores hepáticos benignos. Nault JC et al, Gastroenterology 2013 (144):888-902

Link: HTML

 

Biopsia Hepática

1. Liver biopsy. Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD. Hepatology 2009; 49(3): 1017-44

Link: HTML